New York
Provider Communications
Empire BlueCross BlueShield local precertification change in New York
The following services will be added to precertification for the effective dates listed below.
To obtain precertification, providers can access Availity Essentials* at www.availity.com. Service preapproval is based on member’s benefit plan/eligibility at the time the service is reviewed/approved.
Precertification can help avoid unnecessary charges or penalties by helping to ensure that the member's care is medically necessary and administered at an appropriate network facility and by a network provider.
|
Criteria |
Criteria description |
Codes |
Effective date |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
96365 |
April 1, 2023 |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
96372 |
April 1, 2023 |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
J0456 |
April 1, 2023 |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
J0696 |
April 1, 2023 |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
J0698 |
April 1, 2023 |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
J2540 |
April 1, 2023 |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
S9494 |
April 1, 2023 |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
S9497 |
April 1, 2023 |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
S9500 |
April 1, 2023 |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
S9501 |
April 1, 2023 |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
S9502 |
April 1, 2023 |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
S9503 |
April 1, 2023 |
|
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
S9504 |
April 1, 2023 |
Featured In:
January 2023 Newsletter